1. Home
  2. GPCR vs PRA Comparison

GPCR vs PRA Comparison

Compare GPCR & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • PRA
  • Stock Information
  • Founded
  • GPCR 2016
  • PRA 1976
  • Country
  • GPCR United States
  • PRA United States
  • Employees
  • GPCR N/A
  • PRA N/A
  • Industry
  • GPCR
  • PRA Property-Casualty Insurers
  • Sector
  • GPCR
  • PRA Finance
  • Exchange
  • GPCR Nasdaq
  • PRA Nasdaq
  • Market Cap
  • GPCR 1.1B
  • PRA 1.2B
  • IPO Year
  • GPCR 2023
  • PRA N/A
  • Fundamental
  • Price
  • GPCR $17.59
  • PRA $23.66
  • Analyst Decision
  • GPCR Strong Buy
  • PRA Hold
  • Analyst Count
  • GPCR 7
  • PRA 4
  • Target Price
  • GPCR $76.17
  • PRA $21.00
  • AVG Volume (30 Days)
  • GPCR 734.9K
  • PRA 592.2K
  • Earning Date
  • GPCR 08-11-2025
  • PRA 08-07-2025
  • Dividend Yield
  • GPCR N/A
  • PRA N/A
  • EPS Growth
  • GPCR N/A
  • PRA N/A
  • EPS
  • GPCR N/A
  • PRA 0.83
  • Revenue
  • GPCR N/A
  • PRA $1,140,267,000.00
  • Revenue This Year
  • GPCR N/A
  • PRA N/A
  • Revenue Next Year
  • GPCR N/A
  • PRA $0.58
  • P/E Ratio
  • GPCR N/A
  • PRA $28.73
  • Revenue Growth
  • GPCR N/A
  • PRA N/A
  • 52 Week Low
  • GPCR $13.22
  • PRA $11.27
  • 52 Week High
  • GPCR $45.37
  • PRA $23.95
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 31.53
  • PRA 55.18
  • Support Level
  • GPCR $17.45
  • PRA $23.76
  • Resistance Level
  • GPCR $18.78
  • PRA $23.87
  • Average True Range (ATR)
  • GPCR 0.82
  • PRA 0.10
  • MACD
  • GPCR 0.00
  • PRA -0.04
  • Stochastic Oscillator
  • GPCR 5.00
  • PRA 14.71

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About PRA ProAssurance Corporation

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

Share on Social Networks: